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In Brief
Stronger effects of maternal genomes than paternal ones on offspring have been attributed to maternal RNA and imprinting, but here mutations causing congenital eye disease are shown to result from altered biochemistry that becomes combinatorially disruptive for Vitamin A delivery when it occurs both within the fetus and from maternal tissues supplying the placenta. The findings define a new type of physiological maternal inheritance.
INTRODUCTION
Congenital eye malformations-including microphthalmia, anophthalmia, and coloboma (MAC) disease-affect two in 10,000 births and are an important cause of childhood blindness (Morrison et al., 2002) . The severity depends on timing and the extent that growth and morphogenesis of the developing eye is disrupted (Graw, 2010) . Anophthalmia, or total absence of eyes, is the most extreme form. Microphthalmia (small eyes) and coloboma (ventronasal notch-like defects in the iris and/or retina, arising from incomplete closure of the choroid fissure, see Onwochei et al., 2000) are less severe. These can occur as uni-or bilateral abnormalities, and may coexist in an individual or pedigree. Most cases are isolated, but one-third are associated with systemic birth defects. Few genetic causes have been identified (Williamson and FitzPatrick, 2014) . Loss-of-function SOX2 mutations account for 10% of bilateral anophthalmia (Fantes et al., 2003) , whereas mutations in RX, CHX10, BCOR, HCCS, and PAX6 transcription factors explain other monogenic cases. Signaling pathways mediated by BMP4, GDF6, and SHH may also be genetically disrupted. Finally, disease risk is affected by environmental factors, such as maternal nutrition (Hornby et al., 2003) .
Vitamin A is an essential, fat-soluble nutrient for embryonic development, tissue homeostasis, and physiology. Its most widely recognized function is to supply the visual cycle with 11-cis-retinal (vitamin A aldehyde) for generation of the light-sensitive visual pigment rhodopsin (Lamb and Pugh, 2004) . Consequently, vitamin A deficiency (VAD) first manifests as night blindness (nyctalopia), a reversible loss of visual adaptation to dark environments (Dowling and Wald, 1958) . Vitamin A is also required for epithelial, reproductive, and immune health. At the molecular level, vitamin A is a substrate for synthesis of retinoic acid (RA), a potent signaling molecule needed for vertebrate organogenesis, including eye development (Duester, 2009; Niederreither and Dollé , 2008) . Nutritional studies have long associated maternal vitamin A deficiency with eye malformations, as well as urogenital, diaphragmatic, cardiovascular, and pulmonary defects (Hale, 1933; See and Clagett-Dame, 2009; Wilson et al., 1953) . Recently, genetic links were established between retinoid signaling defects and MAC disease. Loss-of-function mutations in STRA6, encoding the membrane receptor for serum retinol binding protein (RBP), cause autosomal recessive anophthalmia or Matthew-Wood syndrome (OMIM 601186), characterized by structural eye defects, diaphragmatic hernias, cardiac malformations, and pulmonary hypoplasia (Golzio et al., 2007; Pasutto et al., 2007; Casey et al., 2011; Chassaing et al., 2009) . Likewise, mutations in ALDH1A3, encoding retinaldehyde dehydrogenase, account for a subset of recessive MAC cases (T.G., C.M.C., A.S., T.B., and N.M. Ghiasvand, unpublished data; Fares-Taie et al., 2013; Yahyavi et al., 2013) .
Here, we show mutations in the serum RBP gene underlie an autosomal dominant form of MAC that is transmitted with incomplete penetrance and a unique maternal parent-of-origin effect (Sturtevant, 1923) . We further show that the unliganded mutant RBPs bind STRA6 with much greater affinity than wild-type, and consequently are likely to disrupt delivery of vitamin A to target cells, consistent with a dominant-negative effect. These results shed light on the maternal-fetal nutritional interface, genetic susceptibility to vitamin A deficiency, and the etiology of eye malformations.
RESULTS
Autosomal Dominant MAC Disease with Reduced Penetrance and a Maternal Effect A seven-generation pedigree (Family 1) was identified through two probands with anophthalmia ( Figure 1A ). The penetrance of eye disease is incomplete (P = 0.4), based on 54 informative meioses ( Figure S1A ). Carriers have phenotypes There are 11 family members with microphthalmia or coloboma (gray symbols) or clinical anophthalmia (black symbols) and 9 obligate carriers (dotted symbols). (B) Anterior eye and fundus photographs of family members with iris or chorioretinal colobomas (VI-2, VII-2, and VII-3), microphthalmia (III-12 and VII-2), or bilateral clinical anophthalmia (VII-5) and orbital MRI views of VII-5. The T2w coronal MRI shows extraocular muscles (red arrowheads), but absent eye globes. The T2wFS axial image shows bilateral hyperintense orbital cysts (yellow arrowheads); optic nerve head, onh; chorioretinal coloboma, crc; left, L; and right, R. See also ranging from normal to microphthalmia to complete absence of the eyes ( Figure 1B ; Table S1 ). Several individuals have iris and/or chorioretinal colobomas. Transmission is skewed. Nearly all affected individuals (10 of 11) inherited the trait from their mother, such that maternal penetrance is significantly greater than paternal penetrance (P mat = 0.7, P pat = 0.1; Figure S1B ). In the only instance of paternal transmission, one of two monozygous twins (VI-2) was affected.
A New MAC Locus on Chromosome 10q23
We first excluded 23 loci associated with MAC in humans or vertebrate models (Table S2 ) by comparing haplotypes of the two probands. We then examined available family members and performed genome-wide multipoint linkage analysis ( Figures S1C  and S1D ). We applied a simple autosomal dominant (AD) model, scoring only affecteds and obligate carriers. This analysis suggested three candidate regions: 1q41, 10q23, and 19p13, with peak LOD scores >2 ( Figure 1C ). To rank these regions, we included at-risk unaffected family members and applied AD models with uniform (P global = 0.4) or sex-specific (P mat = 0.7, P pat = 0.1) penetrance. This indicated a chromosome 10q23 localization with peak LOD score of 3.01 (Figure 1C) . The 8.2 megabases (Mb) nonrecombinant interval contains 81 genes ( Figure S2 ). Given the importance of vitamin A in eye development (Warkany and Schraffenberger, 1946) and eye malformations associated with STRA6 and ALDH1A3 mutations (T.G., C.M.C., A.S., T.B., and N.M. Ghiasvand, unpublished data); we tested genes in the critical region with roles in vitamin A transport (RBP4) and RA metabolism (CYP26A1 and C1). Dominant RBP4 Mutations in Three Unrelated MAC Families RBP4 encodes serum RBP (Kanai et al., 1968) and contains six exons ( Figure 2A ). Exon screening revealed a missense mutation (c.223G>A, p.A75T) that cosegregated with the disease trait ( Figure 2B ) and was not found in >11,330 control chromosomes. We then screened a cohort of 75 unrelated MAC samples and discovered mutations in two cases, a male with bilateral anophthalmia and neurodevelopmental delay (Family 2), and a female with left microphthalmia and coloboma (Family 3). They share a single missense allele (c.217G>A, p.A73T) on distinct haplotypes, indicating recurrence of the mutation, with maternal transmission in both families ( Figure S3 ).
p.A73T and p.A75T Alter the Retinol-Binding Surface RBP mobilizes all-trans retinol from liver stores to target tissues, including the retinal pigment epithelium and placenta (D'Ambrosio et al., 2011) . As the archetypal lipocalin (Newcomer and Ong, 2000) , RBP folds as a b-barrel with a central hydrophobic ligand cavity ( Figures 2D and S3 ) (Cowan et al., 1990; Zanotti et al., 1993) . Both mutations substitute threonine for alanine, in codons 73 and 75 of b strand C ( Figure 2C ), corresponding to residues 55 and 57 in the mature polypeptide. These alanines face the ligand pocket ( Figure 2D ), contact carbons C4 and C3 of the retinol b-ionone ring, respectively (Cowan et al., 1990) , and are completely conserved among vertebrates ( Figure 2E ).
Two previously reported RBP4 mutations, p.I59N and p.G93D, were associated with recessive night blindness in compound heterozygous sisters (Biesalski et al., 1999) . They correspond to I41N and G75D in b strands B and D of the mature protein, after signal peptide cleavage. These residues also interact with side groups of the b-ionone ring, and biochemical data suggest G75D and I41N proteins bind retinol poorly (Folli et al., 2005) . Molecular modeling shows that A55T and A57T proteins can accommodate retinol, under increased strain due to steric, hydrophilic, and H-bonding effects of the threonine side chain ( Figure S3 ). To understand the allelic heterogeneity and pathogenic basis of MAC disease, we systematically compared properties of wild-type (WT) and mutant RBPs.
A55T and A57T Proteins Are Stably Secreted RBP is constitutively expressed by hepatocytes, retained in the ER and secreted into the bloodstream as holo RBP (Muto et al., 1972; Soprano and Blaner, 1994) , stabilized by three disulfide bonds (Selvaraj et al., 2008) . We first evaluated how missense mutations affect RBP synthesis and secretion in transfected HeLa cells (Melhus et al., 1992) by western analysis, using an N-terminal hemagglutinin (HA) tag ( Figure 3A ). The size (21 kilodalton [kDa] ) and abundance of A55T and A57T proteins in 48 hr conditioned media (CM) were indistinguishable from WT (Figure 3B) . In contrast, G75D and I41N proteins migrated as 42 kDa dimers, or larger multimers (I41N), linked by intermolecular disulfide bonds ( Figures 3B and S4 ). We confirmed this result using glutaraldehyde cross-linked CM, and compared intracellular RBP levels using WT KDEL as an ER retention control ( Figure 3C ). Intracellular G75D and, to a greater extent, I41N were elevated, suggesting a partial secretion defect, with no evidence of ER stress ( Figure S4B ). We conclude that A55T and A57T are secreted as stable 21 kDa monomers, whereas G75D and I41N misfold in the ER, aggregate, and exhibit increased cellular retention.
A55T and A57T Complex Normally with Transthyretin
Under normal conditions, holo RBP and transthyretin (TTR), a 60 kDa homotetramer (Heller and Horwitz, 1974) , are cosecreted in a 1-to-1 molar ratio as a 76 kDa complex (Kanai et al., 1968) . The large size of this complex prevents renal filtration, allowing RBP to remain in circulation (Soprano and Blaner, 1994; van Bennekum et al., 2001 ). In coimmunoprecipitation experiments (Figures 3D and 3E) , human TTR interacted strongly with WT, A55T, and A57T proteins, but poorly with G75D or I41N. Similar results were obtained for bovine TTR, present in the media supplement.
To quantitatively assess the RBP-TTR interaction, we performed reciprocal surface plasmon resonance (SPR) assays with purified TTR and recombinant RBP HA or his-RBP ( Figure 3F ). WT holo RBP bound TTR with 2-to 3-fold greater affinity than apo RBP, giving mean steady state K d values of 0.9 and 2.2 mM respectively, similar to previous reports (Folli et al., 2010; Malpeli et al., 1996) . The affinity of A55T and A57T mutant RBPs was similar or slightly lower than WT in buffered saline (HBS). However, inclusion of nonionic surfactant (0.005% Tween) significantly reduced holo A55T affinity for TTR, presumably by removing retinol (p < 0.001, unpaired t test, and df = 10, see below).
The in vitro behavior of G75D and I41N proteins is consistent with the absence of immunodetectable serum RBP in p.G93D/ p.I59N compound heterozygotes and reduction of RBP in the p.I59N/+ parent, in the setting of normal TTR levels (Biesalski et al., 1999) . Conversely, RBP and TTR levels in p.A75T/+ (Family 1, VI-2, VI-3, and VI-7) and p.A73T/+ (Family 3, II-2) carriers were within normal range (Table S3) .
WT and A57T Proteins Coexist in p.A75T/+ Carrier Plasma To assess the ratio of allotypes in vivo, total RBP was purified from obligate carrier VI-2 plasma ( Figure S5 ), digested with trypsin, and analyzed by mass spectrometry (Figure 4 ). The predicted WT and A57T peptides encompassing amino acid 57 differ by 30 Dalton. Consequently, we identified MALDI-TOF peaks in the 3,100 to 3,220 mass-to-charge ratio (m/z) range corresponding to WT and A57T tryptic peptides, with a 2-to-1 intensity ratio ( Figure 4C ). These were verified by tandem mass spectrometry (MS 2 ) analysis (data not shown) and parallel MS of RBP HA controls. Since the peptides ionize with equal efficiency ( Figure 4D ), we conclude that A57T constitutes one-third of circulating RBP in p.A75T/+ heterozygotes. Because both allotypes were present in carrier plasma, genomic imprinting is unlikely to explain the skewed transmission of the MAC disease ( Figure S1B ). This conclusion is supported by RT-PCR analysis of F1 mice, which showed comparable levels of allelic Rbp4 mRNA transcripts in adult and fetal tissues ( Figure S4C ).
In principle, the unequal ratio of allotypes could be explained by a difference in renal filtration. Under normal circumstances, RBP dissociates from TTR when retinol is delivered to tissues (Malpeli et al., 1996) . Most of the resulting apo RBP is filtered and metabolized by the kidney, but trace amounts are detected in urine, at 1% of serum levels (Raila et al., 2005) and are assumed to represent the RBP content of the glomerular ultrafiltrate proportionally. To test this hypothesis, we evaluated RBP allotypes in p.A75T/+ carrier urine by MS, but found no evidence for increased urinary elimination of A57T relative to WT ( Figure S6 ).
A55T and A57T Proteins Bind Vitamin A Poorly
We tested retinol-binding properties of mutant RBPs using two assays, double radioisotope labeling and fluorescence enhancement. 5B ). We observed a dramatic reduction in retinol binding, as predicted by molecular modeling ( Figure S3E ). A55T bound negligible 3 H-retinol, whereas A57T bound 16% of WT levels. G75D
and I41N mutants also bound very little vitamin A, as expected given their misfolded structures. RBP activity is evidently more sensitive to a threonine substitution at position 55 than 57, consistent with X-ray data placing retinol closer to Ala55 (3.6Å ) than Ala57 (4Å ) (Cowan et al., 1990) . Retinol fluorescence intensity increases 15-fold when it occupies the RBP ligand pocket (Cogan et al., 1976 Figure 5C, filled symbols) . Surprisingly, A55T and A57T both bound retinol well in this assay, with affinities similar to WT (K d $80 nM). These results are consistent with SPR analysis of holo and apo forms interacting with TTR in HBS ( Figure 3F ), but differ sharply from the radioisotope data showing the mutants bind little or no vitamin A ( Figure 5B ).
WT holo RBP is relatively resistant to temperature, pH extremes, and nonpolar solvents (Cogan et al., 1976; Raz et al., 1970) , but sensitive to low ionic strength (Peterson, 1971) . Our disparate findings may be reconciled if A55T and A57T substitutions destabilize RBP contacts with retinol, particularly under adverse environmental conditions, increasing the probability that ligand is released to the solvent. Whereas the initial fluorescence assay was performed in PBS ( Figure 5C , closed symbols), our tissue interstitial space, RBP is continuously exposed to phospholipid membranes and lipoprotein particles (van Meer et al., 2008) . Indeed, retinol-binding activity of the mutant proteins was hypersensitive to ethanol, detergents, and phospholipid vesicles, following an A55T > A57T > WT allelic series. Almost no retinol was bound by A55T in 0.1% PC (K d > 30 mM). Our in vitro data predict that RBP4 heterozygotes may have reduced circulating retinol. Indeed, three p.A75T/+ obligate carriers had fasting serum vitamin A levels below the lower normal limit (Table S3) , ranging from 50%-60% of the reference mean, and plasma retinol fluorescence was reduced ( Figure S5B ).
Increased Binding of A55T and A57T Proteins to the STRA6 Receptor STRA6, or stimulated by RA 6 (Bouillet et al., 1997) , is the transmembrane receptor for RBP that mediates cellular uptake of vitamin A (Kawaguchi et al., 2007) . At target tissues, holo RBP binds STRA6 extracellular loop 6 with high affinity (Kawaguchi et al., 2008) . Following transfer of vitamin A into cells, apo RBP dissociates from the receptor, allowing a new holo RBP molecule to dock (Kawaguchi et al., 2007) . To examine binding of A55T and A57T proteins to STRA6, we performed two sets of experiments. We first applied 35 S-labeled apo WT, holo WT, A55T, or A57T RBP in parallel to human embryonic kidney (HEK) 293T cells transfected with STRA6 myc or control expression vectors and measured 35 S-RBP bound after one hr ( Figures 6A-6C ). In this assay, apo RBP had 3-fold lower steady state binding than holo RBP. More dramatically, STRA6+ cells bound 4 to 7 times more mutant apo RBP than WT holo RBP (p < 0.002, unpaired t tests, and df = 4). These findings, and the mass spectroscopy data (Figure 4 ), suggest that competition may occur between mutant and WT RBP molecules at STRA6 receptors in vivo. To explore this possibility, we mixed 8-250-fold excess unlabeled holo WT with 35 S-labeled RBP HA in parallel assays. In each case, the unlabeled WT competitor displaced much less mutant 35 S-RBP than expected if the binding affinities were equivalent.
To characterize the STRA6-RBP interaction more precisely, we determined the binding affinity (K d ) and rate constant for the approach to equilibrium of mutant and WT RBPs, using a sensitive ELISA method ( Figure S7 ) to measure RBP HA bound to cells and released into the media. These assays show that the mutant proteins have a 30-40-fold greater affinity for STRA6 than WT ( Figure 6D ), with K d values of 1.9 nM (A55T) and 1.5 nM (A57T) compared to 59 nM (WT, p < 0.001, unpaired t tests, and df = 6). In principle, two kinetic mechanisms can explain this striking result, which is central to disease pathogenesis-either the mutant RBP-STRA6 complex dissociates more slowly or the mutant RBPs bind the receptor more rapidly. To distinguish these possibilities, we measured the release of RBP from STRA6+ and control cells at 25 C and 37 C ( Figure 6E ) and calculated forward (k on ) and reverse (k off ) rate constants. As these data show, the major consequence of the mutations is to increase k on by 25-50 fold (p < 0.001, unpaired t tests, df = 42), with no significant change in k off (Figure 6F ; Table S4 ). The pathogenic RBPs thus bind STRA6 with much higher affinity than WT, yet carry little or no vitamin A.
DISCUSSION
Here, we identify RBP4 mutations as the cause for autosomal dominant MAC with incomplete penetrance and skewed maternal transmission. These findings demonstrate a new mode of inheritance in mammals, whereby phenotypic expression is governed by maternal genotype. Our conclusions are supported by linkage analysis, the discovery of independent alleles, evolutionary conservation, the established role of vitamin A in eye morphogenesis, and convergent biochemical, functional, modeling and clinical data which prove A55T and A57T proteins have impaired retinol binding, but resist renal filtration and interact strongly with STRA6. Together, these data provide a simple, but elegant mechanism for disease pathogenesis.
A Unified Disease Model A55T and A57T RBPs act as dominant-negative proteins, most likely by blocking vitamin A delivery at the STRA6 receptor (Figure 7A ). Mutant and WT proteins coexist in plasma (Figure 4 ) and are therefore both secreted. Following translation, A55T and A57T proteins may transiently bind vitamin A in the hepatocyte ER, but if so, are likely to lose a significant fraction of their retinol content in the amphipathic environments of the ER-Golgi compartment and bloodstream ( Figure 5 ). They are otherwise stable and partner with TTR (Figure 3) . At the target cell, mutant RBPs bind STRA6 receptors more avidly than WT (Figure 6 ), with faster association kinetics, increased affinity, and thus longer net occupancy, creating a molecular restriction point. Consequently, delivery of vitamin A from holo RBP should be disrupted.
When the RBP4 mutation is transmitted by the mother, this bottleneck effect is iterated twice, first, at the placenta, involving maternal-derived RBP, and later at the developing eye primordia, involving fetal-derived RBP ( Figure 7B ). In this setting, retinol delivery to fetal tissues may be dramatically reducedand penetrance of eye phenotypes increased-compared to paternal transmission of the same mutation, creating a maternal inheritance pattern that resembles genomic imprinting, but does not involve chromatin or DNA modification. This model is supported by data showing that STRA6 is localized in the placenta and fetal eye (Bouillet et al., 1997; Kawaguchi et al., 2007) and that maternal RBP does not cross the placental barrier in mice (Quadro et al., 2004) . Furthermore, RBP is expressed in extraembryonic tissues that directly participate in retinol transfer across the maternal-fetal interface, including the visceral yolk sac (Johansson et al., 1997; Sapin et al., 1997; Soprano et al., 1986; Ward et al., 1997) . Recently, STRA6 has been shown to mediate retinol efflux from cells as well as influx, loading extracellular apo RBP with cytoplasmic vitamin A (Kawaguchi et al., 2012) . This bidirectional mode may be critical during early development, as fetal RBP originating from the visceral yolk sac or liver can, in principle, ferry retinol stepwise between different STRA6+ cells. Because the mutant RBPs are predicted to disrupt STRA6 docking on both sides, this relay mechanism may be highly sensitive to dominant-negative effects. The labyrinthine zone of the murine chorioallantoic placenta, for example, is a major site of maternal-fetal exchange that strongly expresses STRA6, but not RBP (Bouillet et al., 1997; Johansson et al., 1997) . Likewise in humans, RBP is expressed by the maternal decidua, but not by villous trophoblasts (Johansson et al., 1999) .
When transmitted by the father, the RBP4 mutation can only disrupt vitamin A transfer beyond the placenta. Consequently, the severity of fetal VAD, and the genetic penetrance from males, should be comparatively low. Clinical phenotypes may only be expressed when vitamin A supplied to the placenta is diminished, notably in twin gestation (individual VI-2), where retinol input is divided between two embryos.
Structural Basis for Enhanced STRA6 Binding
RBP is the archetypal lipocalin, an ancient protein family represented in nearly all life forms, including mammals, invertebrates, fungi, and eubacteriae (Flower, 1996; Newcomer and Ong, 2000) . Its ligand pocket is formed by eight anti-parallel beta strands (A-H) with alternating hydrophilic and hydrophobic amino acids, the latter stabilizing retinol. The orientation of the A-B loop, specifically G34-L35-F36-L37, is the only major structural difference between apo and holo RBP crystals at neutral pH (Zanotti et al., 1993) . Threonine substitutions at Ala55 or Ala57, conserved sites deep within the pocket, impair retinol binding and, paradoxically, enhance STRA6 binding. Because these sites are located in the interior of the protein and thus unlikely to contact STRA6, the mutations must increase receptor binding indirectly, by altering RBP conformation. The striking decrease in K d is driven by a large increase in the association rate constant (k on ) with no apparent change in dissociation kinetics (k off ). While relatively unusual (Anderson et al., 1998) , a small number of protein-receptor affinity mutations are known to specifically affect k on (Lahti et al., 2011; Lengyel et al., 2007) . Our findings strongly (F) Histogram comparing STRA6 association (k on ) and dissociation (k off ) rate constants calculated from binding data. The A55T and A57T mutations greatly increase the on rate for RBP binding to STRA6. See also Figure S7 ; Table S4 . Error bars show the SEM for three parallel assays or nonlinear regression of triplicate measurements.
suggest that RBP-STRA6 docking involves a conformational adaptation of RBP and that this initial step, rather than diffusion, limits the binding reaction, consistent with a selected-fit model (Weikl and von Deuster, 2009 ). Complementary changes in STRA6 folding may further stabilize the ligand-receptor complex. The RBP lipocalin undergoes reversible transformation to a molten globule state as pH or solvent polarity is reduced (Calderone et al., 2003; Greene et al., 2006) . This cooperative unfolding has been proposed to occur naturally in the local acidic environ- Each RBP circulates in the maternal or fetal bloodstream in a stable complex bound to TTR, but most of the mutant proteins lack retinol. Upon reaching target tissues, the mutant RBPs bind STRA6 receptors with much higher affinity than WT, acting as dominant-negative particles that block vitamin A delivery. (B) Basis for maternal inheritance. Skewed penetrance arises from functional ''bottlenecks'' that occur at sequential RBP-STRA6 interaction sites in the placenta and fetal eye. Disruption of vitamin A transfer at both levels, coupled with low maternal dietary retinoids (orange and red lines), predispose the fetus to MAC disease when the trait is maternally transmitted. Vitamin A deficiency, VAD. ment at the cell surface, favoring retinol release (Bychkova et al., 1998) , and may be potentiated by interaction with STRA6. We propose that the A55T and A57T mutations, by altering the shape, polarity, and hydrophilicity of the retinol pocket, lower the activation energy for this transition. Consequently, a significant fraction of the mutant RBP population may exist in a partially melted state under normal physiological conditions. These molecules, which may resemble WT intermediates in the RBP-STRA6 binding reaction, presumably account for the enhanced retinol release observed in the presence of organic solvents, surfactants, or phospholipid vesicles. Indeed, retinol dissociates from the mutant RBPs with biphasic kinetics, in PBS following addition of Tx-100 and deoxycholate (DOC), consistent with the existence of R2 discrete holo conformations ( Figure 5D ).
Despite their increased forward reaction rates, the mutant apo RBPs appear to undock normally from STRA6 (Figure 6E) . Likewise, mutant apo and holo RBPs bind TTR with an intrinsic affinity similar to WT (Figure 3 ) and are thus retained in carrier plasma (Figure 4) . Indeed, the enhanced binding of mutant RBP to STRA6+ cell surfaces may in part explain the 1:2 ratio of mutant-to-WT protein in carrier plasma, which cannot be accounted for by unequal urinary loss ( Figure S6 ). RBP normally contacts TTR via three external loops ( Figure 2D ), which form the opening to the retinol pocket, and the C terminus (Newcomer and Ong, 2000) . Although the structural details are not known, these same features are likely to mediate the interaction between RBP and STRA6, allowing retinol to exit (Kawaguchi et al., 2008) . For steric reasons, the RBP-TTR complex must dissociate before receptor binding can occur. This step is driven by a 20-fold difference in the steady state affinity of RBP for STRA6 versus TTR. The alanine substitutions affect RBP binding to former, but not the latter. Structural studies of the mutant proteins may shed light on the conformational steps necessary for STRA6 docking and dissociation and vitamin A release.
RBP4 Mutations, Diet, and Vitamin A Physiology Among organs, the eye is most frequently affected in animal models of vitamin A deficiency (Hale, 1933; See and ClagettDame, 2009; Warkany and Schraffenberger, 1946; Wilson et al., 1953) . Our findings are consistent with this pattern. Despite a global reduction in vitamin A available to the embryo, phenotypes in Family 1 are limited to the eye. Given the central role of retinoids in light perception, this unique sensitivity is striking and may reflect an evolutionary origin of RA signaling in the visual system (Campo-Paysaa et al., 2008; Drager et al., 2000) . Likewise, in humans, total loss of RBP4 is only associated with night blindness, retinal dystrophy, and chorioretinal coloboma (Biesalski et al., 1999; Cukras et al., 2012) .
In addition to retinol, other forms of vitamin A (principally retinyl esters) are delivered to the placenta via chylomicron lipoprotein particles (D'Ambrosio et al., 2011; Wassef and Quadro, 2011) . Indeed, 25% of postprandial retinoids, including retinyl esters (RE) and a/b-carotenoids, travel directly to extrahepatic tissues from intestinal enterocytes via this parallel system, with no involvement of RBP (Goodman et al., 1965) . However, because chylomicron RE are rapidly cleared (Berr, 1992) , RBP accounts for 95%-99% of circulating retinoids in the fasting state (Soprano and Blaner, 1994) . Accordingly, the extent and timing of maternal RE consumption during pregnancy, along with other genetic and/or environmental modifiers, may account for the variable penetrance. For women carrying an RBP4 mutation, careful dietary supplementation with extra vitamin A (RE) in divided doses may be indicated to minimize risk of congenital eye malformations in offspring.
Recent nutritional studies showed that Rbp4 À/À mouse pups born from Rbp4 À/À dams are normal when mothers were fed diets replete with RE (Quadro et al., 2005) . However, these pups developed microphthalmia or anophthalmia in the absence of dietary retinoids and the severity was determined by maternal vitamin A status. In our study, clinical phenotypes were roughly correlated with the magnitude of biochemical effects ( Figure 5 ). Thus, both affected males in Family 2 (A55T) had neurodevelopmental delay in addition to anophthalmia. The discovery of genes that modify plasma retinoid levels, apart from RBP4 and TTR (Mondul et al., 2011) , may shed more light on this disease.
Nutritional Mechanism for Maternal Inheritance of Human Genetic Disease
Maternally skewed inheritance has been reported for other birth defects, including congenital heart disease (Burn et al., 1998; Nora and Nora, 1987) , but the molecular basis is unknown. A study of scoliosis identified gestational hypoxia as an environmental factor that disrupts fibroblast growth factor signaling and somitogenesis, increasing penetrance of Notch pathway defects (Sparrow et al., 2012) . Genetic vitamin A deficiency has been previously suggested as a potential factor for eye malformations (Hornby et al., 2003) . Dominant-negative RBP4 alleles provide a further example of gene x environment effects. Unlike other modes of maternal inheritance, e.g., transmission of ooplasmic mRNA, mitochondrial DNA mutations, or genomic imprinting, these alleles affect fetal and maternal metabolism at a functional level. The sex-specific penetrance has a physiological basis. Our findings highlight the importance of maternal-fetal nutrition and may apply broadly to congenital disease.
EXPERIMENTAL PROCEDURES Clinical Data
Human studies were approved by the University of Michigan (UM); University of California, Davis; and Einstein Medical Center Institutional Review Boards, and informed consent was obtained from all subjects. Eye exams, fundus photography, and magnetic resonance imaging (MRI) were performed at UM (Table S1 ). Blood tests for retinol, RBP, and TTR (prealbumin) were performed on carrier samples collected after a 12 hr fast (Table S3) . MS of plasma and urine samples and other clinical studies are detailed in the Extended Experimental Procedures.
Genetic Analysis
Family 1 genotypes were determined at 51 simple sequence length polymorphism (SSLP) and 6,070 SNP loci using blood, saliva, or buccal DNA. SNPs were assessed using the HL12 BeadChip platform and BeadStudio software (Illumina). Genetic mapping was performed in three steps. Exclusion tests were performed by comparing probands using SSLP markers flanking 23 candidate loci (Table S2 ). Multipoint linkage analysis was then performed on a core pedigree consisting of all living affected individuals, obligate carriers, and spouses (n = 20) using Merlin v1.1.2 (Abecasis et al., 2002) . Finally, linkage analysis was extended to include all collected (n = 33; Figures S1C and S1D) and nodal family members. LOD scores from two subpedigrees ( Figure S1D ) were summed, discarding duplicate phenotypic information (Bellenguez et al., 2009 ) and applying an AD inheritance model with uniform or sex-specific penetrance, estimated from the pedigree.
To identify RBP4 coding variants, we screened 75 unrelated MAC probands and 307 controls (National Institute of Neurological Disorders and Stroke panel) by PCR Sanger sequencing (Table S5 ) and queried the EVS Exome Variant database. Chromosome 10q haplotypes of Families 2 and 3 were compared using the Omni1-Quad SNP platform (Illumina). (Cogan et al., 1976 ) using a microplate reader. To assess binding in nonpolar or amphipathic conditions, parallel assays were performed in PBS with 0 to 50% ethanol; 1% Triton X-100, 0.5% DOC for 0 to 90 min; or 0.1% a-L-PC vesicles dispersed in 5% n-butanol. washed with ice-cold Hanks balanced salt solution (HBSS) and bound RBP was eluted with 25 mM glycine HBSS pH 3. For kinetic analysis, monolayers were washed with DMEM 0.5% BSA and dissociation was followed at 25 C or 37 C by sampling the media at time points from 0 to 90 min. The concentration of RBP HA was determined by an ELISA ( Figure S7 ). 
RBP Secretion and TTR Interaction Assays

STRA6-RBP Binding
